|
Ekelund U, Ward HA, Norat T, Luan J, May AM, Weiderpass E, et al. |
Physical activity and all-cause mortality across levels of overall and abdo... |
Wednesday, March 4, 2015 |
The American journal of clinical nutrition |
|
Ek WE, Lagergren K, Cook M, Wu AH, Abnet CC, Levine D, et al. |
Polymorphisms in genes in the androgen pathway and risk of Barrett's e... |
Tuesday, September 29, 2015 |
International journal of cancer Journal international du cancer |
|
Eisen T, Sternberg CN, Robert C, Mulders P, Pyle L, Zbinden S, Izzedine H, ... |
Targeted therapies for renal cell carcinoma: review of adverse event manage... |
|
J Natl Cancer Inst. |
|
Eisen T, Shparyk Y, Macleod N, Jones R, Wallenstein G, Temple G, Khder Y, D... |
Effect of small angiokinase inhibitor nintedanib (BIBF 1120) on QT interval... |
|
Invest New Drugs |
|
Eisen T, Loembe AB, Shparyk Y, MacLeod N, Jones RJ, Mazurkiewicz M, et al. |
A randomised, phase II study of nintedanib or sunitinib in previously untre... |
Friday, October 9, 2015 |
British journal of cancer |
|
Eisen T, Joensuu H, Nathan PD, Harper PG, Wojtukiewicz MZ, Nicholson S, Bah... |
Regorafenib for patients with previously untreated metastatic or unresectab... |
|
Lancet Oncol. |
|
Eisen T |
Tyrosine kinase inhibitors in renal cell cancer: Losing an empire and yet t... |
Sunday, November 29, 2015 |
European journal of cancer (Oxford, England : 1990) |
|
Eirew P, Steif A, Khattra J, Ha G, Yap D, Farahani H, et al. |
Dynamics of genomic clones in breast cancer patient xenografts at single-ce... |
Thursday, December 4, 2014 |
Nature |
|
Eggermann T, Perez de Nanclares G, Maher ER, Temple IK, Tumer Z, Monk D, et... |
Imprinting disorders: a group of congenital disorders with overlapping patt... |
Friday, November 20, 2015 |
Clinical epigenetics |
|
Eggermann T, Netchine I, Temple IK, Tumer Z, Monk D, Mackay D, et al. |
Congenital imprinting disorders: EUCID.net - a network to decipher their ae... |
Thursday, March 19, 2015 |
Clinical epigenetics |
